Quantum Genomics Société Anonyme reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 2.91 million compared to EUR 2.71 million a year ago. Net loss was EUR 8.85 million compared to EUR 6.18 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1336 EUR | +2.93% | -0.30% | +26.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.04% | 9.83M | |
+40.98% | 54.04B | |
+43.57% | 41.96B | |
-1.10% | 41.92B | |
-7.59% | 28.35B | |
+12.58% | 26.35B | |
-22.11% | 19B | |
+7.76% | 13B | |
+28.48% | 12.28B | |
+24.89% | 12.19B |
- Stock Market
- Equities
- ALQGC Stock
- News Quantum Genomics
- Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2022